Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
PD98059
i
Other names:
PD98059
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Wayne State University
Drug class:
MEK inhibitor
Related drugs:
‹
trametinib (330)
selumetinib (106)
binimetinib (68)
mirdametinib (30)
avutometinib (27)
BAY86-9766 (16)
CI-1040 (15)
tunlametinib (12)
AS703026 (5)
CH4987655 (3)
DS03090629 (3)
LNP3794 (3)
IMM-6-415 (2)
AZD8330 (1)
BI 847325 (0)
GDC-0623 (0)
antroquinonol (0)
MEK Inhibitor (0)
MG-D-1509 (0)
NFX-179 (0)
PF-07799544 (0)
WX-554 (0)
SNR1611 (0)
trametinib (330)
selumetinib (106)
binimetinib (68)
mirdametinib (30)
avutometinib (27)
BAY86-9766 (16)
CI-1040 (15)
tunlametinib (12)
AS703026 (5)
CH4987655 (3)
DS03090629 (3)
LNP3794 (3)
IMM-6-415 (2)
AZD8330 (1)
BI 847325 (0)
GDC-0623 (0)
antroquinonol (0)
MEK Inhibitor (0)
MG-D-1509 (0)
NFX-179 (0)
PF-07799544 (0)
WX-554 (0)
SNR1611 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS G12D
Acute Myelogenous Leukemia
NRAS G12D
Acute Myelogenous Leukemia
PD98059
Sensitive: D – Preclinical
PD98059
Sensitive
:
D
PD98059
Sensitive: D – Preclinical
PD98059
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.